The 72nd Annual Workers' Compensation Educational Conference and 29th Annual Safety & Health Conference (WCI 360) The WCI360 Conference focuses on national workers’ compensation and occupational safety and health industries. During the 72nd Conference, speakers will present on issues of common concern to all Workers’ Comp professionals, regardless of jurisdiction or state, issues that have no geographical boundaries. Mitchell’s is pleased to participate as an exhibitor at the Conference with information on our Workers’ Compensation and Pharmacy Solutions. Our team will be onsite for booth demos, 1x1 meetings and a small meet and greet for our Pharmacy Solutions team. Please contact your Mitchell representative for more detail.
More stories
Implications of Epidiolex FDA Approval on Workers' Compensation
In June 2018, the Federal Drug Administration (FDA) approved Epidiolex, the first plant-derived cannabinoid medicine in the United States. With several states already moving toward legalization of medical marijuana, this is a major step for the federal government.
How Differences in Claim Age and Population Affect Opioid Trends
Management of opioid therapy can be influenced by the types of drugs filled, differing patient populations, and the nature of the injury. Don’t miss our latest video blog where we will review some of the differences that point to the importance of early intervention and identification of long term risk.
Illinois Piloting Opioid Alternative Cannabis Program
The Illinois Alternatives to Opioids Act of 2018 recently went into effect. Learn what this means for workers' compensation patients.
Vermont Department of Labor Proposes Rule Incorporating Opioid Prescribing Guidelines
By Brian Allen, VP of Government Affairs
Vermont Department of Labor Proposes Rule Incorporating Opioid Prescribing Guidelines
The Vermont Department of Labor has proposed a rule that would, by reference, incorporate the Department of Health opioid prescribing guidelines fo
Positive Compound Trends Continue in Work Comp
Utilization and costs associated with compound medications fell significantly for both managed and unmanaged claims in 2017.